1st Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$503,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to 21st Century Cures legislation.

LobbyistCovered position, as disclosed
MARIA FIRVIDA —
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
JOHN MYERS —
BELA SASTRY —

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

Medicare and Medicaid reform including issues related to the Part D program and those related to low income beneficiaries and protected medication classes.

LobbyistCovered position, as disclosed
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
JOHN MYERS —
BELA SASTRY —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); State, Dept of (DOS)

Trade (domestic/foreign) TRD

Trade issues including TPP, TPA, TTIP, Exchange rate policies and China IP and Regulatory Issues.

LobbyistCovered position, as disclosed
BRADLEY ALLEN ROSSIN —

Contacted: Commerce, Dept of (DOC); SENATE; Patent & Trademark Office (PTO); State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

Patent litigation reform. Issues related to intellectual property practices in foreign countries an dimpact on US entities.

LobbyistCovered position, as disclosed
THERESA JOLIVETTE —
JACQUELINE POMFRET KIRBY —
BELA SASTRY —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.